Shockwave Medical Inc
F:36M
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value of 36M.
The Intrinsic Value is calculated as the average of DCF and Relative values:
| US |
|
Abbott Laboratories
NYSE:ABT
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Rapid commoditization of intravascular lithotripsy technology could erode Shockwave’s pricing power and stifle revenue growth, especially as larger competitors develop or acquire similar non-invasive calcification treatment solutions.
Shockwave’s proprietary intravascular lithotripsy platform addresses a critical unmet need in safely treating calcified lesions, solidifying its lead in a high-growth segment of interventional cardiology.
Revenue & Expenses Breakdown
Shockwave Medical Inc
Balance Sheet Decomposition
Shockwave Medical Inc
| Current Assets | 1.3B |
| Cash & Short-Term Investments | 1B |
| Receivables | 124.4m |
| Other Current Assets | 121.7m |
| Non-Current Assets | 368.4m |
| Long-Term Investments | 2.4m |
| PP&E | 113.6m |
| Intangibles | 131.5m |
| Other Non-Current Assets | 120.9m |
| Current Liabilities | 92.3m |
| Accounts Payable | 9.8m |
| Accrued Liabilities | 73m |
| Other Current Liabilities | 9.5m |
| Non-Current Liabilities | 799.7m |
| Long-Term Debt | 732.8m |
| Other Non-Current Liabilities | 66.8m |
Free Cash Flow Analysis
Shockwave Medical Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Shockwave Medical Inc
|
Revenue
|
788m
USD
|
|
Cost of Revenue
|
-102.5m
USD
|
|
Gross Profit
|
685.5m
USD
|
|
Operating Expenses
|
-524.5m
USD
|
|
Operating Income
|
161m
USD
|
|
Other Expenses
|
2.6m
USD
|
|
Net Income
|
163.6m
USD
|
36M Profitability Score
Profitability Due Diligence
Shockwave Medical Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Shockwave Medical Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
36M Solvency Score
Solvency Due Diligence
Shockwave Medical Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Shockwave Medical Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
36M Price Targets Summary
Shockwave Medical Inc
Dividends
Current shareholder yield for
36M is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?